co-add.org
Facilities | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/facilities
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? CO-ADD Screening facilities include. Compound Handling Facilities for medium to high throughput screening. These facilities are located at The University of Queensland's Institute for Molecular Bioscience in Brisbane, Australia. Which are complemented with. Molecular and Cellular Proteomics Mass Spectrometry Facility. UQ Remote Operation Crystallization and X-ray Diffraction Facility. The Centre for Microscopy and Microanalysis.
co-add.org
Blog | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/news-events
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? TedX Talk - Antibiotic Hunters. Our program coordinator for outreach Mathilde Desselle. Explains the idea and process behind CO-ADD’s open-access antimicrobial drug discovery program in a TEDxYouth. UN General Assembly to tackle drug-resistant bacteria. Faces of CO-ADD: interview with Matthew Piggott. Associate Professor Matthew Piggott completed his BSc and PhD at The University of Western Australia. After postdoctoral stints a...
co-add.org
People | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/the-people
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? Superbugs are spreading. The antibiotic discovery pipeline is broken. We want to fix it! We are a determined group of scientific experts and industry leaders from around the world. We are working together to discover new antibiotics that can kill the superbugs that cause millions of infections and deaths around the world. We are based at The University of Queensland's Institute for Molecular Bioscience.
co-add.org
Sending compounds | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/sending-compound-library-for-high-throughput-screening
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? Sending compounds and compound libraries. Is a global initiative of The University of Queensland’s Institute for Molecular Bioscience (UQ IMB) and is funded by Wellcome Trust and UQ. We perform high-throughput antimicrobial screening. In the primary screening. We test against key ESKAPE pathogens,. E coli, K. pneumoniae, A. baumannii, P. aeruginosa, S. aureus. MRSA), as well as the fungi. We require all compounds to be soluble in DM...
co-add.org
The Superbug Crisis | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/superbug-crisis
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? What can you do? Most of us have benefited from the use of antibiotics and we usually take it for granted that there is an antibiotic that works for the particular infection that ‘bugs us’. However, most of us are also aware of the growing presence of superbugs and the ‘broken pipeline of new antibiotics’. Watch ABC Catalyst's special episode on antibiotic resistance. CO-ADD (live Tuesday 19 April, 2016). Although a lot of emphasis ...
co-add.org
Further screening options | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/further-screening-options
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? Research groups who get positive results from initial screening have the option to proceed with us to lead development using our integrated chemistry, biology and pharmacology capabilities. Also possess the expertise and instrumentation to take on collaborative ventures that investigate the mode of action, target validation and genome sequencing projects. The following screening options are not part of the CO-ADD free screening.
co-add.org
Free Screening | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/free-screening
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? Free Antimicrobial Screening of Compound Libraries. Reaches out to chemists in academia and research organisations around the globe who have compounds ‘sitting on shelves’ that were not designed as antibiotics and would not otherwise be screened for antimicrobial activity. We are based at The University of Queensland's Institute for Molecular Bioscience in Brisbane, Australia. Step 1: Primary Screening. In the primary screening.
co-add.org
Partners | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/the-partners
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? Strategic partners and funders. Institute for Molecular Bioscience (UQ IMB). The University of Queensland (UQ). School of Chemistry and Molecular Biosciences. The University of Queensland. Sign up to CO-ADD's mailing list to receive updates and invitations to events, seminars and activities. A welcome reminder to #washyourhands. Microbes we found around the office for #globalhandwashingday.
co-add.org
Champions | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/CO-ADD_Champions
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? Guangzhou General Hospital, China. ND Zelinsky Institute of Organic Chemistry, Moscow. North America and Canada. Princeton University, USA. Professor Adolfo Junior Horn. Professor Christiane Fernandes Horn. Universidade Estadual do Norte Fluminense, Brazil. National Autonomous University of Mexico, Mexico. What do CO-ADD Champions do? Social Scouts: we are on Twitter at @ COADD news. Advocacy: what is the superbug crisis? Sign up to...
co-add.org
Donation | CO-ADD Community for Open Antimicrobial Drug Discovery
http://www.co-add.org/content/donate
CO-ADD Community for Open Antimicrobial Drug Discovery. What can you do? HELP US FIND THE NEXT ANTIBIOTIC. CO-ADD needs your support now to ensure a solution is found before drug-resistant bacteria become a global health catastrophe. In Australia, harmful bacteria kill more than breast and prostate cancer combined. The world has not discovered a new class of antibiotic in 30 years to fight drug-resistant bacterial infections. Support our antibiotic research today! Screen 10 potential antibiotics. We aim ...
SOCIAL ENGAGEMENT